Prescription drug · ANDA
Raloxifene Hydrochloride NDC 50090-7073
Raloxifene hydrochloride 60 mg/1 · Tablet, Film coated · Oral · A-S Medication Solutions
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50090-7073-1 | 5009070730150090707301 | 90 TABLET, FILM COATED in 1 BOTTLE (50090-7073-1)Marketed from Jan 23, 2024 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Raloxifene Hydrochloride
- Generic name (nonproprietary)
- raloxifene hydrochloride
- Active ingredients
- Raloxifene hydrochloride — 60 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- A-S Medication SolutionsNDC labeler code 50090
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 204310
- Marketing start
- Listing expires
- Other FDA classes
- Selective Estrogen Receptor Modulators (Mechanism)
- Identifiers
- Product ID 50090-7073_c6ae957a-83c9-442d-89b2-9febb63c82d4SPL ID c6ae957a-83c9-442d-89b2-9febb63c82d4SPL set ID 804e873e-f48b-4c25-ad7b-41d44f61bddeRxCUI 1490065UNII 4F86W47BR6
- Pharmacologic class
- Estrogen Agonist/Antagonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N450090707301followed by a unit qualifier and the quantityPackage 50090-7073-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Raloxifene hydrochloride is an estrogen agonist/antagonist indicated for: Treatment and prevention of osteoporosis in postmenopausal women. ( 1.1 ) Reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis. ( 1.2 ) Reduction in risk of invasive breast cancer in postmenopausal women at high risk for invasive breast cancer. ( 1.3 ) Important Limitations: Raloxifene hydrochloride tablets are not indicated for the treatment of invasive breast cancer, reduction of the risk of recurrence of breast cancer, or reduction of risk of noninvasive breast cancer. ( 1.3 ) 1.1 Treatment and Prevention of Osteoporosis in Postmenopausal Women Raloxifene hydrochloride tablets are in…
Excerpt only. Read the full label for complete information.
About NDC 50090-7073
- What is NDC 50090-7073?
- 50090-7073 is the product NDC for Raloxifene Hydrochloride, Raloxifene hydrochloride 60 mg/1 tablet, film coated, listed with the FDA by A-S Medication Solutions. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Raloxifene Hydrochloride.
- What is the active ingredient?
- Raloxifene hydrochloride.
- Who is the labeler?
- A-S Medication Solutions, NDC labeler code 50090. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Raloxifene Hydrochloride?
- 19 other product NDCs are listed under this name. See all Raloxifene Hydrochloride NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Raloxifene Hydrochloride products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Raloxifene Hydrochloride | Raloxifene hydrochloride 60 mg/1 | Tablet, Film coatedOral | AvPAK | 50268-694 | 50268-0694-15 |
| Raloxifene hydrochloride | Raloxifene hydrochloride 60 mg/1 | Tablet, CoatedOral | A-S Medication Solutions | 50090-6177 | 50090-6177-01 |
| Raloxifene hydrochloride | Raloxifene hydrochloride 60 mg/1 | Tablet, CoatedOral | Cadila Pharmaceuticals Limited | 71209-082 | 71209-0082-0171209-0082-0571209-0082-11+1 more |
| Raloxifene hydrochloride | Raloxifene hydrochloride 60 mg/1 | Tablet, CoatedOral | Bryant Ranch Prepack | 72162-2418 | 72162-2418-0072162-2418-0172162-2418-03 |
| Raloxifene hydrochloride | Raloxifene hydrochloride 60 mg/1 | Tablet, CoatedOral | Modavar Pharmaceuticals LLC | 72241-010 | 72241-0010-0572241-0010-1172241-0010-13+1 more |
| Raloxifene Hydrochlorideraloxifene | Raloxifene hydrochloride 60 mg/1 | TabletOral | American Health Packaging | 60687-266 | 60687-0266-21 |
| Raloxifene hydrochloride | Raloxifene hydrochloride 60 mg/1 | Tablet, Film coatedOral | Major Pharmaceuticals | 0904-6902 | 00904-6902-04 |
| Raloxifene hydrochloride | Raloxifene hydrochloride 60 mg/1 | Tablet, Film coatedOral | Dr.Reddys Laboratories Inc | 43598-505 | 43598-0505-0143598-0505-1043598-0505-30 |
| Raloxifene hydrochloride | Raloxifene hydrochloride 60 mg/1 | Tablet, Film coatedOral | ScieGen Pharmaceuticals Inc | 50228-306 | 50228-0306-2050228-0306-30 |
| Raloxifene hydrochloride | Raloxifene hydrochloride 60 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 71335-1460 | 71335-1460-0171335-1460-02 |
Other NDCs under ANDA 204310
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Raloxifene Hydrochloride | Raloxifene hydrochloride 60 mg/1 | Tablet, Film coatedOral | NorthStar Rx LLC | 16714-213 |
| Raloxifene Hydrochloride | Raloxifene hydrochloride 60 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 71335-2059 |